{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antifungal", "biofilm", "candida krusei", "hiv", "human immunodeficiency virus", "phospholipase", "proteinase", "resistance", "virulence factors"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37767258", "DateRevised": {"Year": "2023", "Month": "10", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "27"}], "Language": ["eng"], "ELocationID": ["e44213", "10.7759/cureus.44213"], "Journal": {"ISSN": "2168-8184", "JournalIssue": {"Volume": "15", "Issue": "8", "PubDate": {"Year": "2023", "Month": "Aug"}}, "Title": "Cureus", "ISOAbbreviation": "Cureus"}, "ArticleTitle": "Antifungal Resistance Profile, Biofilm Formation, and Virulence Factor Production in Candida krusei Isolates From HIV-Infected Patients in Cameroon.", "Pagination": {"StartPage": "e44213", "MedlinePgn": "e44213"}, "Abstract": {"AbstractText": ["Background Fungal infections mainly caused by <i>Candida krusei</i> are increasing rapidly and represent a serious public health problem in human immunodeficiency virus (HIV)-infected patients. This study aimed to investigate the antifungal susceptibility profile and virulence factors in <i>C. krusei</i> isolated from HIV-infected patients. Methodology Isolates were identified by biochemical and molecular methods. The antifungal resistance profile was established based on the antifungal susceptibility test performed using the Sensititre YeastOne\u2122 (Thermo Fisher Scientific, Waltham, MA) microdilution technique. The production of phospholipase and proteinase was detected by standard methods. Biofilm formation was performed by the microtiter plate method. Results A total of 73 isolates of <i>C. krusei</i> were recovered from stool, oral swabs, vaginal swabs, and urine samples. The highest number of <i>C. krusei</i> isolates (49, 67.05%)was recovered from stool samples. A total of 32.56% of the <i>C. krusei</i> isolates were multidrug-resistant (MDR). The patients living with HIV and not receiving antiretroviral treatment displayed the highest number of <i>C. krusei</i> isolates (29, 39.76%), whereas the patients living with HIV on antiretroviral therapy exhibited the lowest number of <i>C. krusei</i> isolates (2, 2.72%). All isolates\u00a0were categorized as strong biofilm producers. Among the production of hydrolytic enzymes, 25 (58.13%) and 24 (55.81%) of <i>C. krusei</i> isolates were classified as strong phospholipase and proteinase producers, respectively. Conclusion The <i>C. krusei</i> isolates obtained in this study were MDR and strongly expressed biofilm formation and both phospholipase and proteinase hydrolytic enzymes. The results show how pathogenic <i>C. krusei</i> is in the HIV-infected population and will contribute toward the management of <i>C.</i> <i>krusei-</i>related\u00a0infections, which may help improve the life quality of people living with HIV."], "CopyrightInformation": "Copyright \u00a9 2023, Kountchou et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Dschang, Dschang, CMR."}], "LastName": "Kountchou", "ForeName": "Cyrille Levis", "Initials": "CL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Hematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, CMR."}], "LastName": "Noubom", "ForeName": "Michel", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Dschang, Dschang, CMR."}], "LastName": "Ndezo Bisso", "ForeName": "Borel", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire Sion, Unit\u00e9 de Recherche Biom\u00e9dicale, Yaounde, CMR."}], "LastName": "Ngouana Kammalac", "ForeName": "Thierry", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, University of Buea, Buea, CMR."}], "LastName": "Ekpo", "ForeName": "Alfred Itor", "Initials": "AI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, University of Yaound\u00e9 I, Yaound\u00e9, CMR."}], "LastName": "Ngueguim Dougue", "ForeName": "Aude", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Dschang, Dschang, CMR."}], "LastName": "Nangwat", "ForeName": "Claude", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de Biologie Humaine, Institute of Medical Research and Medicinal Plants Studies, Yaounde, CMR."}], "LastName": "Oyono", "ForeName": "Martin", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Infectious Diseases, Assistance Publique H\u00f4pitaux de Marseille, Vecteurs et Infections Tropicales et M\u00e9diterran\u00e9ennes, Aix-Marseille Universit\u00e9, Marseille, FRA."}, {"Identifier": [], "Affiliation": "Department of Infectious Diseases, Institut de Recherche pour le D\u00e9veloppement, Marseille, FRA."}], "LastName": "Ranque", "ForeName": "St\u00e9phane", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Dschang, Dschang, CMR."}], "LastName": "Dzoyem", "ForeName": "Jean Paul", "Initials": "JP"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Cureus", "NlmUniqueID": "101596737", "ISSNLinking": "2168-8184"}, "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Full report \u2014 In danger: UNAIDS global AIDS update 2022. AIDS Update.  [\nJan;\n2023 \n]. 2022. https://www.unaids.org/en/resources/documents/2022/in-danger-global-aids-update https://www.unaids.org/en/resources/documents/2022/in-danger-global-aids-update"}, {"Citation": "Candida species prevalence profile in HIV seropositive patients from a major tertiary care hospital in New Delhi, India. Maheshwari M, Kaur R, Chadha S. J Pathog. 2016;2016:6204804.", "ArticleIdList": ["PMC4820622", "27092278"]}, {"Citation": "Epidemiology and risk factors of oral candidiasis among people living with HIV/AIDS in Ilorin, Kwara State, Nigeria. Omosigho O, Izevbuwa O, Omolade V, Otojareri K. Microbes Infect Dis. 2023;4:231\u2013241."}, {"Citation": "Update on Candida krusei, a potential multidrug-resistant pathogen. Jamiu AT, Albertyn J, Sebolai OM, Pohl CH. Med Mycol. 2021;59:14\u201330.", "ArticleIdList": ["32400853"]}, {"Citation": "A study of candidiasis in HIV reactive patients in a tertiary care hospital, Mysore - South India. Shivaswamy U, Neelambike SM. Indian J Dermatol Venereol Leprol. 2014;80:278.", "ArticleIdList": ["24823420"]}, {"Citation": "Prolonged outbreak of Candida krusei candidemia in paediatric ward of tertiary care hospital. Kaur H, Shankarnarayana SA, Hallur V, et al. Mycopathologia. 2020;185:257\u2013268.", "ArticleIdList": ["PMC7222167", "31983047"]}, {"Citation": "Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile. Scorzoni L, de Lucas MP, Mesa-Arango AC, et al. PLoS One. 2013;8:0.", "ArticleIdList": ["PMC3610750", "23555877"]}, {"Citation": "Current aspects in the biology, pathogeny, and treatment of Candida krusei, a neglected fungal pathogen. G\u00f3mez-Gaviria M, Mora-Montes HM. Infect Drug Resist. 2020;13:1673\u20131689.", "ArticleIdList": ["PMC7293913", "32606818"]}, {"Citation": "Prevalence of antifungal resistance, genetic basis of acquired azole and echinocandin resistance, and genotyping of Candida krusei recovered from an international collection. Khalifa HO, Hubka V, Watanabe A, Nagi M, Miyazaki Y, Yaguchi T, Kamei K. Antimicrob Agents Chemother. 2022;66:0.", "ArticleIdList": ["PMC8846461", "34871096"]}, {"Citation": "Synergistic antibiofilm efficacy of thymol and piperine in combination with three aminoglycoside antibiotics against Klebsiella pneumoniae biofilms. Bisso Ndezo B, Tokam Kuat\u00e9 CR, Dzoyem JP. Can J Infect Dis Med Microbiol. 2021;2021:7029944.", "ArticleIdList": ["PMC8592759", "34790281"]}, {"Citation": "Combined antibiofilm activity of synthetic peptides and antifungal drugs against Candida spp. Bezerra LP, Silva AF, Santos-Oliveira R, et al. Future Microbiol. 2022;17:1133\u20131146.", "ArticleIdList": ["35880557"]}, {"Citation": "Extracellular hydrolytic enzyme activities of the different Candida spp. isolated from the blood of the intensive care unit-admitted patients. Pandey N, Gupta MK, Tilak R. J Lab Physicians. 2018;10:392\u2013396.", "ArticleIdList": ["PMC6210849", "30498309"]}, {"Citation": "Candida albicans genotyping and relationship of virulence factors with fluconazole tolerance in infected pediatric patients. Mashaly GE, Zeid MS. Infect Drug Resist. 2022;15:2035\u20132043.", "ArticleIdList": ["PMC9037425", "35480061"]}, {"Citation": "Routine identification and mixed species detection in 6,192 clinical yeast isolates. Cassagne C, Normand AC, Bonzon L, et al. Med Mycol. 2016;54:256\u2013265.", "ArticleIdList": ["26613703"]}, {"Citation": "Clinical and Laboratory Standards Institute (CLSI). Performance standards for antifungal susceptibility testing of yeasts. CLSI supplement M60.  [\nJan;\n2023 \n]. 2017. https://clsi.org/media/1895/m60ed1_sample.pdf https://clsi.org/media/1895/m60ed1_sample.pdf"}, {"Citation": "Clinical and Laboratory Standards Institute (CLSI). Epidemiological cutoff values for antifungal susceptibility testing. CLSI supplement M59.  [\nJan;\n2023 \n]. 2018. https://clsi.org/media/1895/m60ed1_sample.pdf https://clsi.org/media/1895/m60ed1_sample.pdf"}, {"Citation": "No correlation between biofilm formation, virulence factors, and antibiotic resistance in Pseudomonas aeruginosa: results from a laboratory-based in vitro study. Gajd\u00e1cs M, Bar\u00e1th Z, K\u00e1rp\u00e1ti K, Szab\u00f3 D, Usai D, Zanetti S, Donadu MG. Antibiotics (Basel) 2021;10:1134.", "ArticleIdList": ["PMC8471826", "34572716"]}, {"Citation": "Relationship between biofilm-formation, phenotypic virulence factors and antibiotic resistance in environmental Pseudomonas aeruginosa. Behzadi P, Gajd\u00e1cs M, Pall\u00f3s P, et al. Pathogens. 2022;11:1015.", "ArticleIdList": ["PMC9503712", "36145447"]}, {"Citation": "Multiple antibiotic resistant index of gram-negative bacteria from bird droppings in two commercial poultries in Enugu, Nigeria. Afunwa RA, Ezeanyinka J, Afunwa EC, Udeh A, Oli A, Unachukwu M. Open J Med Microbiol. 2020;10:171\u2013181."}, {"Citation": "Efficacy of Syzygium aromaticum essential oil on the growth and enzymatic activity of pathogenic Candida albicans strains. Hekmatpanah A, Sharifzadeh A, Shokri H, Abbaszadeh S, Nikaein D. Curr Med Mycol. 2022;8:12\u201319.", "ArticleIdList": ["PMC9548078", "36340432"]}, {"Citation": "Bouchara JP, Pihet M, Gentile L, Cimon B, Chabasse D. Cahier de Formation Biologie M\u00e9dicale. Paris, France: Bioforma; [ Jan; 2023 ]. 2010. Les levures et levuroses. (Article in French)"}, {"Citation": "Epidemiology and antifungal susceptibility testing of non-albicans Candida species colonizing mucosae of HIV-infected patients in Yaound\u00e9 (Cameroon) Ngouana TK, Toghueo RM, Kenfack IF, et al. J Mycol Med. 2019;29:233\u2013238.", "ArticleIdList": ["31204235"]}, {"Citation": "Antifungal susceptibility pattern of Candida isolated from cutaneous candidiasis patients in eastern Guangdong region: a retrospective study of the past 10 years. Bilal H, Hou B, Shafiq M, Chen X, Shahid MA, Zeng Y. Front Microbiol. 2022;13:981181.", "ArticleIdList": ["PMC9389287", "35992679"]}, {"Citation": "Mycoses in northeastern Brazil: epidemiology and prevalence of fungal species in 8\u00a0years of retrospective analysis in Alagoas. de Albuquerque Maranh\u00e3o FC, Oliveira-J\u00fanior JB, Dos Santos Ara\u00fajo MA, Silva DM. Braz J Microbiol. 2019;50:969\u2013978.", "ArticleIdList": ["PMC6863203", "31140098"]}, {"Citation": "Epidemiology and prevalence of oral candidiasis in HIV patients from Chad in the post-HAART era. Taverne-Ghadwal L, Kuhns M, Buhl T, et al. Front Microbiol. 2022;13:844069.", "ArticleIdList": ["PMC8891798", "35250957"]}, {"Citation": "The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon. Ambe NF, Longdoh NA, Tebid P, et al. Pan Afr Med J. 2020;36:23.", "ArticleIdList": ["PMC7392032", "32774600"]}, {"Citation": "Drug Resistance and novel therapeutic approaches in invasive candidiasis. Murphy SE, Bicanic T. Front Cell Infect Microbiol. 2021;11:759408.", "ArticleIdList": ["PMC8713075", "34970504"]}, {"Citation": "Estimation of biofilm, proteinase & phospholipase production of the Candida species isolated from the oropharyngeal samples in HIV-infected patients. Lahkar V, Saikia L, Patgiri SJ, Nath R, Das PP. Indian J Med Res. 2017;145:635\u2013640.", "ArticleIdList": ["PMC5644298", "28948954"]}, {"Citation": "Virulence factors of Candida species from the oral mucosa and prostheses of elderly people from a riverside community in the Amazon state, Brazil. Silva DM, Souza TC, Alencar CFC, Souza IS, Bandeira MFCL, Fernandes OCC. Rev Odontol UNESP. 2019;48:0."}, {"Citation": "Proteinase and phospholipase activity as virulence factors in Candida species isolated from blood. Mohan das V, Ballal M. Rev Iberoam Micol. 2008;25:208\u2013210.", "ArticleIdList": ["19071887"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "8", "Day": "24"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "4", "Minute": "13"}, {"Year": "2023", "Month": "8", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["37767258", "PMC10521937", "10.7759/cureus.44213"]}}], "PubmedBookArticle": []}